?? Our Annual Thanksgiving Potluck at Palleon Pharmaceuticals was a success! It was a heartwarming celebration of good food, great company, and shared gratitude. From homemade dishes to meaningful conversations, it’s moments like these that remind us of the power of collaboration.
Palleon Pharmaceuticals
生物技术研究
Waltham，Massachusetts 6,383 位关注者
Clinical-stage biotech company developing drugs that harness glyco-immunology to treat cancer and inflammatory diseases
关于我们
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer. The company’s proprietary Convergence Platform integrates technologies and insights from world-renowned scientific leaders in the fields of glycoscience and human immunology to create a novel approach to treating cancer. By targeting multiple immune cell types, Glyco-Immune Checkpoint inhibitors will tackle resistance to first-generation immuno-oncology agents, and make possible a wider range of rational combination therapies to treat cancer. While Palleon is focused primarily on oncology, the Convergence Platform is applicable to other therapeutic areas including infectious diseases, neurodegeneration, inflammation, and fibrosis. The company is advancing its pipeline and development programs with a $47.6 million Series A financing from leading biotech venture investors SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures.
- 网站
-
https://www.palleonpharma.com
Palleon Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Waltham，Massachusetts
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Biotechnology、Immuno-Oncology、Clinical Development和Glyco-Immune Checkpoint Inhibitors
地点
-
主要
获取路线
266 Second Ave
US，Massachusetts，Waltham，02451
Palleon Pharmaceuticals员工
动态
-
?? Save the Date for Glyco27! The 8th Canadian Glycomics Symposium is happening in May 2025, and you won’t want to miss it! This premier event will bring together leading experts in glycomics from across Canada and around the world to share cutting-edge research and innovative breakthroughs in the field. #glycotime #glyco27 ?? https://www.glyco27.org/
-
?? Meet the changemakers of glycobiology! We’ve curated a Glycobiology Innovators Twitter List to connect you with top researchers, scientists, and thought leaders who are shaping the future of this dynamic field. From groundbreaking research to emerging technologies, these experts are leading conversations that will influence the next generation of discoveries. ?? https://bit.ly/3YMk8sJ #glycotime #biotech
Glycobiology Innovators
-
Congratulations to Vijayashree Mysore, PhD for winning a Palleon Innovation Award! Her efforts have been vital to our programs targeting autoimmunity. We are grateful for your hard work and creativity, Vijaya! Your contributions really help to advance our mission. ? #PalleonPeople #glycotime
-
-
Palleon will present results from our Phase 1/2 GLIMMER 01 trial of E-602 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting tomorrow. Our findings establish the first proof of mechanism for glycan editing and antitumor activity in patients with solid tumors. ? Read more here: https://bit.ly/3YHWVYD ? #glycotime #SITC24
-
-
We're excited to announce the winners of this year’s Palleon Innovation & Collaboration (PIC) Awards! Our annual awards recognize the extraordinary accomplishments of our colleagues who exemplify innovation and teamwork in their different roles.??? ? A huge congratulations to all the individuals and teams who went above and beyond to make a difference this year! #PalleonPeople
-
-
?? Happy Halloween from all of us at Palleon! We kicked off the day with delicious waffles and pancakes while bonding as a team. A big congratulations to Wayne Gatlin for winning the best costume contest, representing our EAGLE platform! ?? Wishing everyone a fun and spooky season!
-
-
-
-
-
+2
-
-
Thank you, Carolyn Bertozzi, for your inspiring message about why we do what we do. We are proud to have you as one of our Scientific Co-Founders at Palleon! #Glycotime
“Your purpose as a scientist is not to achieve fame or money, that is not your purpose, those might be side effects and good for you, that could be wonderful for you but it is a side effect, it is not the main goal. The main goal is to make discoveries and gift them to humanity. And those discoveries and that knowledge stays with humanity long after you are gone.” - Carolyn Bertozzi on the scientist's purpose Bertozzi was awarded the 2022 chemistry prize for utilising click chemistry in living organisms. She developed bioorthogonal reactions which take place inside living organisms without disrupting the normal chemistry of the cell. #NobelPrize
-
-
Find us at the Society for Immunotherapy of Cancer (SITC) Annual Meeting! We will be presenting Phase 1/2 findings from our GLIMMER-01 trial of E-602 in patients with solid tumors during both rapid oral and poster presentations. ? Learn more: https://bit.ly/4fiGEAk #SITC24
-